Differential regulation of human alveolar macrophage-derived interleukin-1β and tumor necrosis factor-α by iron
- 1 December 1998
- journal article
- research article
- Published by Elsevier in Journal of Laboratory and Clinical Medicine
- Vol. 132 (6) , 497-506
- https://doi.org/10.1016/s0022-2143(98)90128-7
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Risks of Parenteral Deferoxamine for Acute Iron PoisoningJournal of Toxicology: Clinical Toxicology, 1996
- Iron Chelation Decreases NF-kB and HIV Type 1 Activation due to Oxidative StressAIDS Research and Human Retroviruses, 1995
- Interleukin-1-mediated acute lung injury and tolerance to oxidative injury.Environmental Health Perspectives, 1994
- Regulation of the transcription factors NF-κB and AP-1 by redox changesChemico-Biological Interactions, 1994
- Most free‐radical injury is iron‐related: It is promoted by iron, hemin, holoferritin and vitamin c, and inhibited by desferoxamine and apoferritinThe International Journal of Cell Cloning, 1994
- N-Acetylcysteine and glutathione as inhibitors of tumor necrosis factor productionCellular Immunology, 1992
- Oxidant/Antioxidant Imbalance: Role in the Pathogenesis of COPDRespiration, 1992
- Oxidative injury amplifies interleukin-1-like activity produced by human monocytesInternational Journal of Immunopharmacology, 1989
- Role of metals in oxygen radical reactionsJournal of Free Radicals in Biology & Medicine, 1985
- Prevention of granulocyte-mediated oxidant lung injury in rats by a hydroxyl radical scavenger, dimethylthiourea.Journal of Clinical Investigation, 1984